Filing Details
- Accession Number:
- 0001516551-24-000114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 21:14:59
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-19 21:14:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516551 | Skye Bioscience Inc. | SKYE | Pharmaceutical Preparations (2834) | 450692882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861554 | A. Paul Grayson | C/O Skye Bioscience, Inc. 1250 El Camino Real Suite 100 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-15 | 307 | $5.55 | 345,945 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-18 | 86,244 | $4.99 | 259,701 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax obligations in connection with the vesting and settlement of performance-based restricted stock units.
- The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.
Billionaire Hedge Funds
